Here are relevant reports on : mushroom-growing-kits-market
-
Base Editing Market by Product (Platform, Reagents & Kits, Plasmids), Service (gRNA Design, Cell Line Engineering), Type, Targeted base (Cytosine, Adenine), Application (Drug Discovery, Agriculture, Veterinary), and Region - Global Forecast to 2028
The global base editing market, valued at US$260 million in 2022, stood at US$270 million in 2023 and is projected to advance at a resilient CAGR of 15.2% from 2023 to 2028, culminating in a forecasted valuation of US$549 million by the end of the period.The growth of the base editing market is largely driven by the rising prevalence of genetic diseases, and the increasing recognition of the role of genetic mutations in various diseases has fueled the demand for precise gene editing technologies.
- Published: December 2023
- Price: $ 4950
- TOC Available:
-
Exosome Diagnostics and Therapeutics Market by Type (Diagnostics, Therapeutics), Product & Service (Instruments, Kits, Reagents), Source (Stem Cells, Blood, Blood Plasma, Urine), Application (Cancer, Musculoskeletal, CVD) - Global Forecast to 2032
The global exosome diagnostics and therapeutics market, valued at US$33 million in 2023, stood at US$59 million in 2024 and is projected to advance at a resilient CAGR of 81.2% from 2024 to 2032, culminating in a forecasted valuation of US$6,848 million by the end of the period. The growth of this market is driven by factors such as the increasing collaborations & commercialization initiatives, emerging potential of exosome-based liquid biopsy, and growing outsourcing of exosome manufacturing activities.
- Published: June 2024
- Price: $ 4950
- TOC Available:
-
Sterility Testing Market by Product (Kits & Reagents, Instrument, Services), Test (Membrane Filtration, Direct Inoculation), Application (Pharma, Biological Manufacturing, Medical Device Manufacturing), End User (Pharma, Biotech) & Region - Global Forecasts to 2028
The global sterility testing market, stood at US$1.1 billion in 2023 and is projected to advance at a resilient CAGR of 10.5% from 2023 to 2028, culminating in a forecasted valuation of US$1.9 billion by the end of the period. Factors such as expanding pharmaceutical & biotechnology production capacities, increasing development of novel biopharmaceutical products, and rising investments in life sciences research are expected to drive market growth.
- Published: March 2023
- Price: $ 4950
- TOC Available:
-
UK Next-generation Sequencing Market by Product (Reagents, Kits, Platforms), Service (CHIP Sequencing, Whole Genome, Methyl, RNA Sequencing), Technology (SBS, Nanopore), Workflow (Sequencing, Data Analysis), Application, Competition - Forecast to 2031
The UK next-generation sequencing market, valued at USD 0.73 billion in 2025, stood at USD 0.80 billion in 2026 and is projected to advance at a resilient CAGR of 14.8% from 2026 to 2031, culminating in a forecasted valuation of USD 1.59 billion by the end of the period. The report profiles key players such as Illumina, Inc. (US), Thermo Fisher Scientific Inc. (US), Oxford Nanopore Technologies plc. (UK), QIAGEN (Netherlands), Agilent Technologies, Inc. (US), F. Hoffmann-La Roche Ltd. (Switzerland), PacBio (US), and Eurofins Scientific (Luxembourg).
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Protein Expression Market by Product (Instruments, Reagents, Kits, Consumables, Software, Services), System Type (Mammalian, Insect, Yeast), Workflow (Cloning, Translation, PTM), Scale, Protein Type, Application, Competition - Global Forecast to 2031
The global protein expression market is projected to reach USD 7.65 billion by 2031, growing at a CAGR of 8.3% during the forecast period (2026–2031). The report covers key segments, regional analysis, and competitive landscape across the market ecosystem.
- Published: May 2026
- Price: $ 4950
- TOC Available:
-
Asia Pacific Epigenetics Market by Offering [Enzymes, Kits & Reagents, Software, Services], Method [DNA Methylation, Histone Modification], Technique [NGS, PCR], Application [Oncology, Immunology, Developmental Biology], End User - Forecast to 2030
The Asia Pacific epigenetics market, valued at US$0.44 billion in 2024, stood at US$0.49 billion in 2025 and is projected to advance at a resilient CAGR of 14.6% from 2025 to 2030, culminating in a forecasted valuation of US$0.97 billion by the end of the period. The Asia Pacific epigenetics market is experiencing growth, driven by increasing demand for precise biomarker discovery and multi-omics research across oncology, immunology, and precision medicine programs.
- Published: September 2026
- Price: $ 4950
- TOC Available:
-
Cystatin C Assay Market by Product (Analyzers, Kits, Reagents), Method (ELISA, PETIA, IFA, CLIA, PENIA), Application (Diagnostics, Research), Sample Type (Blood, Urine), End User (Hospitals, Clinical Laboratories) & Region - Global Forecast to 2028
The global cystatin C assay market, valued at US$352 million in 2022, stood at US$377 million in 2023 and is projected to advance at a resilient CAGR of 7.5% from 2023 to 2028, culminating in a forecasted valuation of US$540 million by the end of the period.The growth of this market is majorly driven by the Increasing adoption of POC testing and presence of supportive government policies. However, raising awareness among healthcare providers about the benefits of cystatin C testing can be challenging.
- Published: October 2023
- Price: $ 4950
- TOC Available:
-
Albumin & Creatinine Tests Market by Product (Analyzers, Cartridges (PoC, Tabletop), Dipsticks, Kits, Reagents), Type (Blood & Urine Creatinine, Urine Albumin, Glycated Albumin), Enduser (Hospital, Diagnostic & Research Labs) - Global Forecast to 2025
The global albumin & creatinine tests market growth is primed to transition from $987 million in 2020 to $2,103 million by 2025, showcasing a strong CAGR of 16.3%. The growth of this market is driven by the growing prevalence of kidney disorders and diseases, the rising adoption of POC diagnostics, and the increasing prevalence of chronic conditions.
- Published: January 2021
- Price: $ 4950
- TOC Available:
-
Single Cell Analysis Market by Product (Consumables (Beads, Kits, Reagents), Instruments), Cell Type (Human, Animal), Technique (Flow Cytometry, NGS, PCR, Microscopy), Application (Research (Cancer, Neurology), Medical (NIPT, IVF)) - Global Forecast to 2030)
The global single-cell analysis market, valued at US$3.55 billion in 2024, stood at US$3.81 billion in 2025 and is projected to advance at a resilient CAGR of 14.7% from 2025 to 2030, culminating in a forecasted valuation of US$7.56 billion by the end of the period.Growth in this market can be attributed to factors such as the rising incidence of cancer and immunological disorders, technological developments in single-cell analysis products, the growing focus on the advancement of stem cell research, and the increasing focus on the biotechnology sector.
- Published: May 2025
- Price: $ 4950
- TOC Available:
-
Intracranial Pressure Monitor Market by Application (Traumatic Brain Injury, Intracerebral Hemorrhage, Meningitis), by Product (Accessories, Kits, Monitor, Probes), and by End User (Hospitals, Home, and Other End Users) - Global Forecast to 2019
The intracranial pressure monitoring is important neurosurgical equipment. The monitoring of intracranial pressure is used in treating severe traumatic brain injury patients. Studies conducted suggest that raised ICP is the commonest cause of death in neurosurgical patients and in head injury patients. Approximately 40% of patients who are admitted in an unconscious state have raised ICP, and in 50% of those die due to raised ICP. Thus intracranial patient monitors help in keeping the pressure levels in normal range. Latest techniques involve telemetric ICP probes inserted in the brain to monitor ICP in several neurosurgical procedures. The telemetric device allows for constant monitoring over a period of weeks which makes the patient completely free to follow daily activities.
- Published: October 2026
- Price: $ 4950
- TOC Available:
Records 31 to 40 of 50
